Clinical Trial: Hemp-Derived CBD Supplement Associated with Improved HDL Cholesterol Levels


Well-Known Member
Sep 19, 2009
Reaction score
Mariposa County CA
Clinical Trial: Hemp-Derived CBD Supplement Associated with Improved HDL Cholesterol Levels

Thursday, 11 June 2020
Stow, OH: The daily administration of a commercially available, hemp-derived CBD oil extract is associated with improved HDL cholesterol levels, according to clinical data published in the Journal of Dietary Supplements.

Investigators affiliated with The Center for Applied Health Sciences in Ohio and Lindenwood University in Missouri assessed the health effects of a commercially available hemp extract versus placebo in 65 overweight but otherwise healthy participants. Extracts contained 15mg of CBD. Participants consumed either the extract or a placebo daily for a period of six weeks.

Researchers reported that those taking CBD experienced improved HDL (high-density lipoprotein aka "good") cholesterol levels as compared to controls. Subjects consuming the extract also acknowledged improvements in sleep and an overall improvement in their quality of life. No significant adverse events were reported.

Authors concluded, "Overall, these findings suggest that supplementation with this hemp extract at the provided dosage in the men and women studied exhibited improvements in HDL cholesterol, tended to support psychometric measures of perceived sleep quantity and stress response, perceived life pleasure, and is well tolerated in healthy human subjects."

Several observational studies have previously identified an association between cannabis use and elevated HDL levels, along with other decreased metabolic risk factors.

Full text of the study, "Effects of hemp extract on markers of wellness, stress resilience, recovery and clinical biomarkers of safety in overweight, but otherwise healthy subjects," appears in the Journal of Dietary Supplements.

Link To NORML Action Center: NORML's Action Center - NORML - Working to Reform Marijuana Laws